Nitika Pharmaceutical Specialities Private Limited - Company Profile

It is a chemicals and materials private limited company based in Nagpur, Maharashtra, India, established in 2011.
2011 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Nitika Pharmaceutical Specialities Private Limited

Nitika Pharmaceutical Specialities Private Limited, a active private limited company, was established on 12 March 2011 in Nagpur, Maharashtra, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24230MH2011PTC214662. Registered under ROC Roc Nagpur. it is unlisted. It has an authorized capital of ₹9.50 Cr and a paid-up capital of ₹3.14 Cr.

Formerly known as Nitika Pharma Specialities Private Limited. It upholds a compliant status. Employing 122 professional, Its leadership includes Ravleen Singh Khurana (Director), Manojkumar Badrinarayan Agrawal (Director), Parvinder Singh (Director). Past directors included Manojkumar Badrinarayan Agrawal, Parvinder Singh, Mangesh Eknath Bhad. It holds ₹180.53 Cr open charges and ₹20.77 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Fortune Ritz, F. No. 101, Pl. 240/A,, Near Raja Rani Square, Civil Lines,, Nagpur, Maharashtra, 440001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2011PTC214662

  • Registration Number

    214662

  • Incorporation Date

    12 March 2011

  • Authorized Capital

    ₹9.50 Cr

  • Paid-Up Capital

    ₹3.14 Cr

  • ROC Code

    Roc Nagpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 9.50 Cr
  • Paid Up Capital ₹ 3.14 Cr
  • Company Age 14 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 180.53 Cr
  • Satisfied Charges ₹ 20.77 Cr
  • Revenue Growth **** 17.44%
  • Profit Growth **** 2.39%
  • Ebitda **** 20.44%
  • Net Worth 20.26%
  • Total Assets **** 24.35%
Company report

Nitika Pharmaceutical Specialities Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nitika Pharmaceutical Specialities Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nitika Pharmaceutical Specialities Private Limited?
Current Directors
Name Designation Appointment Date Status
Ravleen Singh Khurana Director 12 Mar 2011 Current
Manojkumar Badrinarayan Agrawal Director 10 Jul 2018 Current
Parvinder Singh Director 11 Jul 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 31 Jul 2015 Past
Pramod Abcsdd Director 31 Mar 2022 Past
Pramod Abcsdd Director 13 Jul 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nitika Pharmaceutical Specialities.

Nitika Pharmaceutical Specialities Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.44% increase. The company also saw a slight improvement in profitability, with a 2.39% increase in profit. The company's net worth Soared by an impressive increase of 20.26%.

Nitika Pharmaceutical Specialities revenue growth over time
Nitika Pharmaceutical Specialities profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 17.44%
*******
*******
*******
*******
Revenue from Operations
*******
 16.41%
*******
*******
*******
*******
Total Assets
*******
 24.35%
*******
*******
*******
*******
Profit or Loss
*******
 2.39%
*******
*******
*******
*******
Net Worth
*******
 20.26%
*******
*******
*******
*******
EBITDA
*******
 20.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nitika Pharmaceutical Specialities?

In 2023, Nitika Pharmaceutical Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,805,276,727.00

Satisfied Charges

₹207,670,000.00

Charges Breakdown by Lending Institutions
  • Others : 100.00 Cr
  • Axis Bank Limited : 42.19 Cr
  • Bank Of India : 38.00 Cr
  • Hdfc Bank Limited : 0.34 Cr
Latest Charge Details
Date Lender Amount Status
16 Jul 2025 Bank Of India ₹3.00 Cr Open
30 May 2025 Others ₹100.00 Cr Open
12 Dec 2023 Bank Of India ₹35.00 Cr Open
22 Mar 2022 Axis Bank Limited ₹42.19 Cr Open
27 Nov 2020 Hdfc Bank Limited ₹3.40 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Nitika Pharmaceutical Specialities?

Nitika Pharmaceutical Specialities has a workforce of 122 employees as of Dec 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nitika Pharmaceutical Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nitika Pharmaceutical Specialities's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nitika Pharmaceutical Specialities
Recent Activity within the Organization
  • Charges

    The activity A charge with Bank Of India amounted to Rs. 3.00 Cr with Charge ID 101130521 was registered on 16 Jul 2025. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101107432 was registered on 30 May 2025. was documented.

  • Charges

    A charge registered on 20 May 2023 via Charge ID 100729002 with Bank Of India was fully satisfied on 07 May 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Nitika Pharmaceutical Specialities Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Nitika Pharmaceutical Specialities Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Nagpur. was completed.

  • Charges

    The activity A charge registered on 28 Mar 2012 via Charge ID 10350851 with Bank Of India was fully satisfied on 15 Mar 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nitika Pharmaceutical Specialities Private Limited?

The CIN of Nitika Pharmaceutical Specialities Private Limited is U24230MH2011PTC214662.

Where is Nitika Pharmaceutical Specialities Private Limited headquartered?

Nitika Pharmaceutical Specialities Private Limited is headquartered at Fortune Ritz, F. No. 101, Pl. 240/A,, Near Raja Rani Square, Civil Lines,, Nagpur, Maharashtra, 440001.

When was Nitika Pharmaceutical Specialities Private Limited incorporated?

Nitika Pharmaceutical Specialities Private Limited was incorporated on 12 March 2011.

Who are the current directors of Nitika Pharmaceutical Specialities Private Limited?

The current directors of Nitika Pharmaceutical Specialities Private Limited are

What is the primary industry of Nitika Pharmaceutical Specialities Private Limited?

The primary industry of Nitika Pharmaceutical Specialities Private Limited is Manufacturing.

Is Nitika Pharmaceutical Specialities Private Limited a listed company?

Nitika Pharmaceutical Specialities Private Limited is unlisted.

What is the capital structure of Nitika Pharmaceutical Specialities Private Limited?

The authorized capital of Nitika Pharmaceutical Specialities Private Limited is ₹9.50 Cr, and the paid-up capital is ₹3.14 Cr.

What is the compliance status of Nitika Pharmaceutical Specialities Private Limited?

The compliance status of Nitika Pharmaceutical Specialities Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available